Ann Surg

1. WANG J, Wu Z, Verhoeven RHA, Goense L, et al
   A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy: A Study Based on the Netherlands Cancer Registry.
   Ann Surg. 2025 Sep 23. doi: 10.1097/SLA.0000000000006869.
   

   >> Share

   
   

   
   Br J Oral Maxillofac Surg

2. SCHEMBRI T, Oikonomou C, Holmes S
   Adapting the University of Washington Quality of Life Questionnaire for Oral Cancer to trauma patients.
   Br J Oral Maxillofac Surg. 2025 Aug 8:S0266-4356(25)00200.
   

   >> Share

   
   

   
   Cancer Res

3. ZHANG D, Hu J, Zhu G, Liu C, et al
   CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma.
   Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-24-3866.
   

   >> Share

   
   

   
   Dis Esophagus

4. STRAATMAN J, Abu Hejley A, Klevebro F, Fuchs H, et al
   Analysis of in-hospital mortality following transthoracic esophagectomy for cancer.
   Dis Esophagus. 2025;38:doaf076.
   

   >> Share

   
   
5. KOOIJ CD, Goense L, Kingma BF, den Boer RB, et al
   Early versus late oral feeding regimens following esophagectomy: a propensity score-matched observational cohort.
   Dis Esophagus. 2025;38:doaf068.
   

   >> Share

   
   
6. DE MUL N, Vernooij LM, van Haastregt NCJ, de Groot EM, et al
   Judicious use of critical care resources by predicting the need for routine ICU admission following esophagectomy.
   Dis Esophagus. 2025;38:doaf075.
   

   >> Share

   
   

   
   Head Neck

7. WANG J, Ludwig ML, Kulkarni A, Birkeland AC, et al
   CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma.
   Head Neck. 2025 Sep 23. doi: 10.1002/hed.70048.
   

   >> Share

   
   

   
   Histopathology

8. PATIL A, Jiezhen TL, Kosiorek H, Brown IS, et al
   An international inter-rater agreement study in the challenging diagnosis of squamous dysplasia of the oesophagus.
   Histopathology. 2025;87:573-583.
   

   >> Share

   
   

   
   Int J Cancer

9. VERHOEVEN RHA, Kuijper SC, Slingerland M, Wijnhoven B, et al
   Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival.
   Int J Cancer. 2025 Sep 23. doi: 10.1002/ijc.70168.
   

   >> Share

   
   
10. OSWAL K, Barman S, Kerr AR, Zaman M, et al
    Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India.
    Int J Cancer. 2025 Sep 19. doi: 10.1002/ijc.70160.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

11. XU X, Zhang C, Wang G, Dong B, et al
    Correlation of TgAb With Clinicopathological Features and Unfavorable Efficacy of 131I Ablation in PTC.
    J Clin Endocrinol Metab. 2025;110:e3245-e3251.
    

    >> Share

    
    
12. CIRELLO V, Colombo C, Tosi D, Manzo A, et al
    TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer.
    J Clin Endocrinol Metab. 2025 Feb 1:dgaf056. doi: 10.1210.
    

    >> Share

    
    

    
    Oral Oncol

13. SAMUEL M
    Disparities in oral cancer screening in India: reflections on NFHS 5 evidence and pathways forward.
    Oral Oncol. 2025;169:107693.
    

    >> Share

    
    
14. MISRA SR, Das R
    Financial instability, insurance, and transportation barriers in oral cancer care: contrasting perspectives between the United States and India.
    Oral Oncol. 2025;169:107692.
    

    >> Share

    
    
15. CHENG H, Jiang M, Kim S, Moshiri A, et al
    Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma.
    Oral Oncol. 2025;170:107687.
    

    >> Share

    
    
16. AL MAQRASHI ZAA, Kartolo A, Meyers BM
    Resectable locally advanced head and neck squamous cell carcinoma: cut first or immune checkpoint inhibitors first?
    Oral Oncol. 2025;170:107704.
    

    >> Share

    
    

    
    PLoS Comput Biol

17. COLEGROVE HL, Monnat RJ Jr, Feder AF
    Epithelial competition determines gene therapy potential to suppress Fanconi Anemia oral cancer risk.
    PLoS Comput Biol. 2025;21:e1012915.
    

    >> Share

    
    

    
    PLoS One

18. CLATOT F, Even C, Daste A, Borel C, et al
    Defining a need for rapid response and practical guidance for recurrent and metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) management in France: A Delphi consensus.
    PLoS One. 2025;20:e0332413.
    

    >> Share

    
    
19. LIN R, Qin R, Zhang Y, Guan Y, et al
    Combined application of BNLF2b antibody with VCA-IgA, Rta-IgG, and Zta-IgA in nasopharyngeal carcinoma screening in the Guangxi region.
    PLoS One. 2025;20:e0332606.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

20. JAIN S
    Metabolic Response at (18)F-FDG PET/CT as a Prognostic Marker after Induction Chemotherapy or Chemoradiotherapy in Localized Esophageal Squamous Cell Carcinoma.
    Radiol Imaging Cancer. 2025;7:e259024.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share